Use of Positron Emission Tomography in Pharmacokinetic Studies to Investigate Therapeutic Advantage in a Phase I Study of 120-Hour Intravenous Infusion XR5000 Purpose: Despite dose calculation using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback